The MedTech Actuator aggressively accelerates and funds MedTech, HealthTech and BioTech start-ups.
By surrounding new ventures with the industry experts and support they need to navigate the complexities of deep technology innovation, the MedTech Actuator supports countries to drive economic growth, augment existing industries and create the jobs of the future.
The MedTech Actuator does this by de-risking MedTech, HealthTech and BioTech commercialisation, developing and curating local innovation ecosystems – including more than 85 partners covering all aspects of commercialisation. These include the best of global MedTech corporations, regulatory and clinical trial experts, product manufacturers, IP specialists and more.
The MedTech Actuator was founded in Australia in 2018 and has since expanded into Asia Pacific, with offices in Australia and Singapore and a program presence in Australia, Singapore, India, and Japan.
Over 80 start-ups have now been supported, creating at least 174 new jobs. This program has been supported by REDI.
|Consortium lead||MedTech Actuator|
|Consortium members|| |
Artesian Venture Partners
|Project duration||March 2017 - March 2019 (Finished)|
|Contact||Buzz Palmer, MedTech Actuator - email@example.com|
Visit MedTech Actuator for more information | Twitter: medtechactuator | LinkedIn: MedTech Actuator